Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Breast Cancer Research and Treatment
|
December 2, 2021
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
Phuong Dinh, J Dinny Graham, Elisabeth N Elder, et al.
Ebiomedicine
|
March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification
Cristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
BMJ Open
|
June 19, 2025
Implementation and effectiveness of a nurse-enabled, shared-care follow-up model for early breast cancer survivors (The IBIS-Survivorship Study): protocol for a stepped-wedge cluster randomised trial
Raymond J Chan, Fiona Crawford-Williams, Bogda Koczwara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 25, 2017
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer
Jia-Min B Pang, Peter Savas, Andrew P Fellowes, et al.
Breast Cancer Research : BCR
|
July 8, 2024
Stromal lymphocytes are associated with upgrade of B3 breast lesions
Tanjina Kader, Elena Provenzano, Madawa W Jayawardana, et al.
BMJ Open
|
December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes
Amit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2025
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence Rates
Frank Vicini, Chirag Shah, Karuna Mittal, et al.
Annals of Surgical Oncology
|
September 21, 2010
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study
Carla Suzanne Fisher, David J Cole, Michael Mitas, et al.
The Journal of Pathology
|
February 13, 2019
Molecular comparison of interval and screen-detected breast cancers
Dane Cheasley, Na Li, Simone M Rowley, et al.
Annals of Surgery
|
May 29, 2004
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study
William E Gillanders, Kaidi Mikhitarian, Renee Hebert, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Breast Cancer Research and Treatment
|
December 2, 2021
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing
Phuong Dinh, J Dinny Graham, Elisabeth N Elder, et al.
Ebiomedicine
|
March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification
Cristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
BMJ Open
|
June 19, 2025
Implementation and effectiveness of a nurse-enabled, shared-care follow-up model for early breast cancer survivors (The IBIS-Survivorship Study): protocol for a stepped-wedge cluster randomised trial
Raymond J Chan, Fiona Crawford-Williams, Bogda Koczwara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 25, 2017
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer
Jia-Min B Pang, Peter Savas, Andrew P Fellowes, et al.
Breast Cancer Research : BCR
|
July 8, 2024
Stromal lymphocytes are associated with upgrade of B3 breast lesions
Tanjina Kader, Elena Provenzano, Madawa W Jayawardana, et al.
BMJ Open
|
December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes
Amit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2025
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence Rates
Frank Vicini, Chirag Shah, Karuna Mittal, et al.
Annals of Surgical Oncology
|
September 21, 2010
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study
Carla Suzanne Fisher, David J Cole, Michael Mitas, et al.
The Journal of Pathology
|
February 13, 2019
Molecular comparison of interval and screen-detected breast cancers
Dane Cheasley, Na Li, Simone M Rowley, et al.
Annals of Surgery
|
May 29, 2004
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study
William E Gillanders, Kaidi Mikhitarian, Renee Hebert, et al.
Page
of 12